Conmed (CNMD) Non-Current Debt (2010 - 2026)
Conmed's (CNMD) quarterly Non-Current Debt came in at $657.0 million in Q2 2026, down 25.43% on a YoY basis from $881.1 million in Q2 2025, and down 23.61% quarter-over-quarter from $860.2 million in Q1 2026.
Analysis
Conmed (CNMD) Non-Current Debt (2010 - 2026) Analysis & Trends
Conmed (CNMD) has reported Non-Current Debt for 17 consecutive years, with $657.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Debt fell 25.43% year-over-year to $657.0 million; the trailing twelve-month figure through Jun 2026 stood at $657.0 million (down 25.43% YoY), and the FY2025 full-year result was $834.2 million, down 7.83% from the prior year.
- Non-Current Debt slipped to $657.0 million in Q2 2026 per CNMD's latest filing, from $860.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.0 billion in Q3 2022 and bottomed at $657.0 million in Q2 2026.
- Historically, Non-Current Debt has averaged $909.3 million across 5 years, with a median of $941.1 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Non-Current Debt soared 47.36% in 2022, then decreased 25.43% in 2026.
- Over 5 years, Non-Current Debt stood at $985.1 million in 2022, then dropped by 1.21% to $973.1 million in 2023, then dropped by 7.0% to $905.1 million in 2024, then fell by 7.83% to $834.2 million in 2025, then decreased by 21.24% to $657.0 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $657.0 million, $860.2 million, and $834.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Conmed | 1.42 Bn | 1.38 Bn | 197.46 Mn | 657.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 657.05 Mn |
| Mar 31, 2026 | 860.16 Mn |
| Dec 31, 2025 | 834.23 Mn |
| Sep 30, 2025 | 853.01 Mn |
| Jun 30, 2025 | 881.11 Mn |
| Mar 31, 2025 | 891.44 Mn |
| Dec 31, 2024 | 905.07 Mn |
| Sep 30, 2024 | 940.09 Mn |
| Jun 30, 2024 | 965.17 Mn |
| Mar 31, 2024 | 990.11 Mn |
| Dec 31, 2023 | 973.14 Mn |
| Sep 30, 2023 | 942.17 Mn |
| Jun 30, 2023 | 971.48 Mn |
| Mar 31, 2023 | 995.28 Mn |
| Dec 31, 2022 | 985.08 Mn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 982.43 Mn |
| Mar 31, 2022 | 703.54 Mn |
| Dec 31, 2021 | 672.41 Mn |
| Sep 30, 2021 | 703.34 Mn |